Brookwood Investment Group LLC Acquires New Position in GE HealthCare Technologies Inc. $GEHC

Brookwood Investment Group LLC acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 5,857 shares of the company’s stock, valued at approximately $434,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Glenview Trust co grew its position in GE HealthCare Technologies by 4.4% during the first quarter. Glenview Trust co now owns 3,294 shares of the company’s stock valued at $266,000 after purchasing an additional 139 shares in the last quarter. Silver Oak Securities Incorporated grew its position in GE HealthCare Technologies by 4.6% during the second quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock valued at $236,000 after purchasing an additional 140 shares in the last quarter. Chicago Capital LLC increased its holdings in GE HealthCare Technologies by 2.2% in the second quarter. Chicago Capital LLC now owns 6,551 shares of the company’s stock worth $485,000 after buying an additional 141 shares during the last quarter. Fort Washington Investment Advisors Inc. OH increased its holdings in GE HealthCare Technologies by 4.2% in the second quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company’s stock worth $263,000 after buying an additional 143 shares during the last quarter. Finally, Knuff & Co LLC increased its holdings in GE HealthCare Technologies by 1.5% in the first quarter. Knuff & Co LLC now owns 10,276 shares of the company’s stock worth $829,000 after buying an additional 150 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $79.40 on Wednesday. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The company has a fifty day simple moving average of $74.99 and a 200 day simple moving average of $72.80. The company has a market cap of $36.25 billion, a P/E ratio of 16.27, a P/E/G ratio of 2.99 and a beta of 1.13. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. GE HealthCare Technologies’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.00 EPS. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is currently 2.87%.

Wall Street Analysts Forecast Growth

Several analysts have commented on GEHC shares. Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $93.00 to $83.00 in a research report on Tuesday, October 7th. Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Barclays started coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price for the company. BTIG Research boosted their target price on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the stock a “buy” rating in a research report on Monday, October 13th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $85.20.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.